gdc

Newsworthy

FDA and CDC Investigate Outbreak of Vaping-Related Illness
FDA Approvals, News & UpdatesNewsworthyWeb Exclusives
In the past week, the US Food and Drug Administration (FDA) has released 2 public announcements related to the use of vaping products.
Polivy a New Targeted Immunotherapy Approved for Patients with B-Cell Lymphoma
FDA Approvals, News & UpdatesLymphomaNewsworthy
In June 2019, the FDA approved a new type of immunotherapy called Polivy, for use in combination with other drugs, in patients with previously treated diffuse large B-cell lymphoma (DLBCL), offering new options for patients whose cancer has returned.
FDA Approvals, News & UpdatesLeukemiaNewsworthy
In July 2018, the FDA approved Tibsovo (ivo-sidenib; from Agios Pharmaceuticals), the first IDH1 inhibitor, for the treatment of adults with relapsed (returning) or refractory (not responding to treatment) acute myeloid leukemia (AML) and a susceptible IDH1 genetic mutation.
Page 1 of 6
Results 1 - 10 of 60

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country